Johnson & Johnson News

Johnson & Johnson is a large and diverse company, so staying up-to-date with developments, company performance, and their plans for the future is not easy. That's why Wiser created the Johnson & Johnson news digest. It is delivered once a day and contains the key articles from around the web in order to keep you informed. Johnson & Johnson is primarily involved in the health sector. Its interests are spread across 275 different companies in 60 countries. It was founded in 1886 and its headquarters is in New Jersey. Worldwide it employs about 128,000 people and its main consumer brands include Band-Aid, Johnson's baby products and Neutrogena. It also has a medical devices and diagnostics sector, and a pharmaceuticals sector. Challenges exist in the later, particularly regarding the competition from generic versions of some of its drugs. Its research and development pipeline is also watched with interest, as is its movements in terms of expansion - further acquisitions, particularly in the medical devices field, are expected. Make sure you do not miss any Johnson & Johnson news, analysis or information by registering for the free Wiser daily email.

Recent Johnson & Johnson News Coverage
 
Your Weekly Recommendations Thursday, November 23, 2017
 
Recommended for you
Johnson & Johnson drug succeeds in newly diagnosed multiple myeloma patients: study
Reuters • Bill Berkrot
Johnson & Johnson: Dividend King With Good Total Return And Dividend Growth
Seeking Alpha • William Stamm
Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) from EMA in Newly Diagnosed Multiple Myeloma
BusinessWire
Health Care Sector Update for 11/21/2017: JNJ, PFE, ABT, MRK, AMGN, ARDX, MDT, NVO
nasdaq.com
J&J Wins Major Defense Verdict in Talcum Lawsuit
Technologist • Esq, George Khoury
J&J reports declining spine sales in Q3 – what to expect in Q4
Becker's Spine Review • Mackenzie Garrity
Report: India eyes penalties for Johnson & Johnson over metal-on-metal hips
Mass Device • Brad Perriello
European Commission Extends License for Janssen’s ZYTIGA® Plus Prednisone / Prednisolone to Include Earlier Stage Prostate Cancer Patients
BusinessWire
Valeant: Bausch & Lomb Is #1 Contact Lenses In China E-Retailing
Seeking Alpha • Peter Tan
Johnson & Johnson beauty challenge crowdsources new skincare tech
FiercePharma • Beth Snyder
 
Recommended for You
Cancer, Health Care Industry
Johnson & Johnson drug succeeds in newly diagnosed multiple myeloma patients: study
ReutersBill Berkrot
() - Johnson & Johnson’s blockbuster multiple myeloma drug Darzalex when added to a standard therapy regimen reduced the risk of disease progression or death by 50 percent compared with standard therapy alone in patients not previously treated for the blood cancer,...
Share
Economic Policy, Finance
Johnson & Johnson: Dividend King With Good Total Return And Dividend Growth
Seeking AlphaWilliam Stamm
Summary Johnson & Johnson total return over-performed the DOW average for my 58.0 month test period by 33.72%, which is great. Johnson & Johnson Has increased its dividend for 55 years in a row (a dividend king) and presently has a yield...
Share
Cancer, Financial Regulatory Bodies
Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) from EMA in Newly Diagnosed Multiple Myeloma
BusinessWire
BEERSE, Belgium--(BUSINESS WIRE)--Janssen-Cilag International NV today announced the submission of a Type II variation application to the European Medicines Agency (EMA), for the immunotherapy DARZALEX®▼ (daratumumab). The application seeks to broaden the existing marketing authorisation to include daratumumab in combination with bortezomib,...
Share
Economic Policy, Health Care Industry
Health Care Sector Update for 11/21/2017: JNJ, PFE, ABT, MRK, AMGN, ARDX, MDT, NVO
nasdaq.com
Top Health Care Stocks Top Health Care Stocks JNJ 0 3 JNJ 0 3 PFE 0 1 PFE 0 1 ABT flatABT flat MRK flatMRK flat AMGN 0 1 AMGN 0 1 Health care shares were mixed in pre market trading Tuesday...
Share
Cancer, Johnson & Johnson
J&J Wins Major Defense Verdict in Talcum Lawsuit
TechnologistEsq, George Khoury
Given the massive worldwide market share in the personal care products sector, Johnson and Johnson is no stranger to legal battles. Over the past couple years, the company has been facing hundreds of claims that their talcum powders, or baby powders, contain...
Share
Johnson & Johnson, Stryker Corp
J&J reports declining spine sales in Q3 – what to expect in Q4
Becker's Spine ReviewMackenzie Garrity
Although reporting $19.7 billion total sales in the third quarter of 2017, Johnson & Johnson's spine division saw a decline in sales, according to Market Realist. Here's what you need to know. 1. With the emergence of competitors, such as Medtronic, Zimmer...
Share
Johnson & Johnson, Medical Devices
Report: India eyes penalties for Johnson & Johnson over metal-on-metal hips
Mass DeviceBrad Perriello
Johnson & Johnson (NYSE:JNJ) could reportedly be on the hook again for the metal-on-metal hip implants it pulled from the market in 2010, this time in India and for much less than it’s cost the company elsewhere. The world’s second-largest medical device...
Share
Cancer, Johnson & Johnson
European Commission Extends License for Janssen’s ZYTIGA® Plus Prednisone / Prednisolone to Include Earlier Stage Prostate Cancer Patients
BusinessWire
BEERSE, Belgium--(BUSINESS WIRE)--Janssen-Cilag International NV (Janssen) today announced that the European Commission (EC) has granted approval to broaden the existing marketing authorisation for ZYTIGA® (abiraterone acetate) plus prednisone / prednisolone to include an earlier stage of metastatic prostate cancer than its current...
Share
Brand Management, Health Finance
Valeant: Bausch & Lomb Is #1 Contact Lenses In China E-Retailing
Seeking AlphaPeter Tan
Summary Bausch & Lomb is the leading contact lenses brand in China, compared to Acuvue, Alcon (including CIBA Vision), and CooperVision. Bausch & Lomb is the most popular brand on Alibaba platforms - Tmall, Taobao, as well as Sigo and Kede. Bausch...
Share
Entrepreneurship, Johnson & Johnson
Johnson & Johnson beauty challenge crowdsources new skincare tech
FiercePharmaBeth Snyder
Calling all digital entrepreneurs: Johnson & Johnson is looking for creative tech skincare solutions in its Digital Beauty QuickFire Challenge. The contest runs through Jan. 19, with entries expected to address skin health management, skincare personalization and even technology that could improve...
Share